GlassScriptPhysician profile
Philip A Reed
NPI 1447361308
$977.02
in general payments reported to CMS, 2019-2025
16 companies · $244 in 2025
The $244 reported for 2025 was more than what 79% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2020: $96.77 · 2022: $191 · 2023: $151 · 2024: $144 · 2025: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $539.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $229.00 | 2022-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $203.35 | 2019-2024 | Jornay Pm |
| Merck Sharp & Dohme LLC | $100.22 | 2023-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Sanofi Pasteur INC. | $84.80 | 2019-2025 | |
| Collegium Pharmaceutical, INC. | $61.02 | 2025 | Jornay Pm |
| Neos Therapeutics, LP | $39.77 | 2019 | |
| Glaxosmithkline, LLC. | $37.61 | 2019-2023 | Bexsero |
| Ultragenyx Pharmaceutical INC. | $31.35 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $30.33 | 2020 | |
| Supernus Pharmaceuticals, INC. | $28.25 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $27.66 | 2025 | Zoryve |
| Tris Pharma INC | $26.54 | 2020 | |
| Kyowa Kirin, INC. | $25.80 | 2025 | |
| Azurity Pharmaceuticals, INC. | $21.92 | 2025 | Alvesco |
| Seqirus USA INC | $16.52 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $12.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Reed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.